Table 3 Clinical trials evaluating the efficacy of MSCs for treating salivary gland damage
From: Autologous mesenchymal stem cells offer a new paradigm for salivary gland regeneration
Type of damage | MSC source | Transplant Type | NCT # | Trial phase | Country | Year | References |
|---|---|---|---|---|---|---|---|
SS | BM | Allogeneic | NCT00953485 | ½ | China | 2009 | |
SS | AD | Allogeneic | NCT04615455 | 2 | Denmark | 2020 | |
IR | AD | Autologous | NCT02513238 | 2 | Denmark | 2015 | |
IR | BM | Autologous | NCT03743155 | 2 | Spain | 2018 | |
IR | AD | Allogeneic | NCT03874572 | 1 | Denmark | 2019 | |
IR | AD | Autologous | NCT03876197 | ½ | Denmark | 2019 | |
IR | BM | Autologous | NCT04007081 | n/a | USA | 2019 | |
IR | AD | Allogeneic | NCT04776538 | 2 | Denmark | 2021 |